Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2.

Yongqiang ZhouJinjing HuLu LiuMengchao YanQiyu ZhangXiaojing SongYan LinDan ZhuYongjian WeiZongli FuLiming HuYue ChenXun Li

Published in: Cancer cell international (2021)

Gly-tRF enhances LCSC-like cell properties and promotes EMT by targeting NDFIP2 and activating the AKT signalling pathway. Gly-tRF plays tumor-promoting role in HCC and may lead to a potential therapeutic target for HCC.

Keyphrases

signaling pathway
induced apoptosis
epithelial mesenchymal transition
single cell
cell cycle arrest
cell proliferation
cell therapy
stem cells
oxidative stress
risk assessment
human health
climate change